Miquel y Costas & Miquel S.A. (MCM)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 9.740 |
|---|---|
| 52-week range | 9.620 – 14.600 |
| Return, 1 month / 3 months | −10.1% / −14.7% |
| Return, 1 year / 3 years | −10.8% / +18.1% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 18.1% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 0.12M EUR |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Miquel y Costas & Miquel is a Spanish paper manufacturer based in Barcelona. It makes thin and lightweight papers, most notably cigarette paper, along with specialty papers used in industrial and technical applications. Its customers include tobacco companies and manufacturers that need specialised paper products, and it also supplies papers for other commercial uses. The company operates as an industrial paper producer with a focus on narrow-niche paper grades.
Miquel y Costas & Miquel S.A. trades under the code MCM on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Miquel y Costas & Miquel S.A. (MCM) trades on the Madrid Exchange in Spain. It last closed at EUR 9.740 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 147 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.8% and over the last three months it fell 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.8% | ||
| From 52-week high | -33.3% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.7% | ||
| 6-month return | -15.2% | ||
| 12-month return, skipping the last month | -0.8% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 18.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.12M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.5% |
|---|---|
| 1 month | −10.1% |
| 3 months | −14.7% |
| 6 months | −15.2% |
| 1 year | −10.8% |
| 3 years | +18.1% |
| 5 years | +9.5% |
Signals
| 50-day / 200-day average | 10.799 / 11.301 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.325 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | EUR 0.0935 |
| 14 Jul 2026 | EUR 0.1151 |
| 14 Apr 2026 | EUR 0.0995 |
| 15 Dec 2025 | EUR 0.0949 |
| 14 Oct 2025 | EUR 0.0923 |
| 15 Jul 2025 | EUR 0.1126 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.